Zobrazeno 1 - 10
of 185
pro vyhledávání: '"Oude-Rengerink K"'
Autor:
Zhou G, de Vos S, Schuiling-Veninga CC, Bos J, Oude Rengerink K, Pasmooij AMG, Mol PG, de Bock GH, Hak E
Publikováno v:
Clinical Epidemiology, Vol Volume 15, Pp 923-937 (2023)
Guiling Zhou,1 Stijn de Vos,1 Catharina CM Schuiling-Veninga,1 Jens Bos,1 Katrien Oude Rengerink,2 Anna Maria Gerdina Pasmooij,2 Peter GM Mol,2,3 Geertruida H de Bock,4 Eelko Hak1 1Unit of Pharmaco-Therapy, -Epidemiology and -Economics (PTEE), Depart
Externí odkaz:
https://doaj.org/article/4fb6c07420ad4a028e82e38e85717c8a
Autor:
Mitroiu, M.1,2 (AUTHOR) M.Mitroiu@umcutrecht.nl, Oude Rengerink, K.1,2 (AUTHOR), Teerenstra, S.1,3 (AUTHOR), Pétavy, F.4 (AUTHOR), Roes, K. C. B.1,3 (AUTHOR)
Publikováno v:
Trials. 7/23/2020, Vol. 21 Issue 1, p1-14. 14p. 1 Color Photograph, 3 Diagrams, 2 Charts.
Autor:
Zuidgeest, MGP, Goetz, I, Meinecke, AK, Boateng, D, Irving, EA, Van Thiel, GJM, Welsing, PMJ, Oude-Rengerink, K, Grobee, DE
Methodologies incorporating Real World Elements into clinical trial design (also called pragmatic trials) offer an attractive opportunity to assess the effect of a treatment strategy in routine care and as such guide decision making in practice. Upta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2659::42e328cd9267d26d302e91436a810972
https://zenodo.org/record/6384842
https://zenodo.org/record/6384842
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lemmers, M, Verschoor, M A C, Oude Rengerink, K, Naaktgeboren, C, Opmeer, B C, Bossuyt, P M, Huirne, J A F, Janssen, C A H, Radder, C, Klinkert, E R, Langenveld, J, Catshoek, R, Van der Voet, L, Siemens, F, Geomini, P, Van Hooff, M H, Van der Ploeg, J M, Coppus, S F P J, Ankum, W M, Mol, B W J, MisoREST study group
STUDY QUESTION: Is curettage more effective than expectant management in case of an incomplete evacuation after misoprostol treatment for first trimester miscarriage? SUMMARY ANSWER: Curettage leads to a higher chance of complete evacuation but expec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10691::519a1b2681e1ca1576f3754278af0611
https://dspace.library.uu.nl/handle/1874/346614
https://dspace.library.uu.nl/handle/1874/346614
Autor:
Weber, Maaike A, Milstein, Dan M J, Ince, Can, Oude Rengerink, Katrien, Roovers, Jan-Paul W R, Oude Rengerink, K
Publikováno v:
Neurourology and Urodynamics, 34(8), 723. Wiley-Liss Inc.
AIM: To describe the vaginal microcirculatory architecture and capillary density parameters using sidestream dark-field imaging (SDFI), and determine feasibility and reliability of this method. METHODS: In nine healthy female volunteers SDFI measurem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::20b91d3b47cd1c90ac0243ccf658da1e
https://dspace.library.uu.nl/handle/1874/332271
https://dspace.library.uu.nl/handle/1874/332271
Autor:
van de Waarsenburg, Kim, Vollebregt, Astrid, Milani, Fred, Oude Rengerink, Katrien, van der Vaart, Huub, Oude Rengerink, K
Publikováno v:
International Urogynecology Journal And Pelvic Floor Dysfunction, 26(9), 1399. Springer London
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::a270ad581345a9223e12e2150de9fe67
https://dspace.library.uu.nl/handle/1874/332267
https://dspace.library.uu.nl/handle/1874/332267
Autor:
van der Ploeg, J M, Oude Rengerink, K, van der Steen, A, van Leeuwen, J H S, Stekelenburg, J, Bongers, M Y, Weemhoff, M, Mol, B W, van der Vaart, C H, Roovers, J-P W R, Dutch Urogynaecology Consortium
OBJECTIVE: To compare transvaginal prolapse repair combined with midurethral sling (MUS) versus prolapse repair only. DESIGN: Multi-centre randomised trial. SETTING: Fourteen teaching hospitals in the Netherlands. POPULATION: Women with symptomatic s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10691::f180032aae73611b524b7d4595a05358
https://dspace.library.uu.nl/handle/1874/332269
https://dspace.library.uu.nl/handle/1874/332269
Autor:
Oude Rengerink, Katrien, Logtenberg, Sabine, Hooft, Lotty, Bossuyt, Patrick M, Mol, Ben Willem, Oude Rengerink, K
Publikováno v:
BMC Pregnancy and Childbirth [E], 15(207). BioMed Central
BMC Pregnancy and Childbirth
BMC pregnancy and childbirth, 15(1). BioMed Central
BMC Pregnancy and Childbirth
BMC pregnancy and childbirth, 15(1). BioMed Central
Background Pregnant women were excluded from clinical trials until the 1990s, but the Food and Drug Administration nowadays allows - and even encourages - responsible inclusion of pregnant women in trials with adequate safety monitoring. Still, rando